Central nervous system protein targets (CNS protein targets)

Central nervous system (CNS) protein targets represent a diverse collection of molecular structures, including G protein-coupled receptors, ion channels, transporters, and enzymes, that facilitate communication within the brain and spinal cord (StatPearls, 2023). These proteins are fundamental to biological functions such as neurotransmission, synaptic plasticity, and sensory processing (Nature Reviews Drug Discovery, 2021). Dysregulation or genetic mutations in these targets are central to the pathogenesis of neurodegenerative diseases like Alzheimer's and Parkinson's, as well as psychiatric conditions such as depression and schizophrenia (NIH, 2024). Therapeutic intervention typically involves small molecules or biologics designed to modulate these proteins to restore physiological balance (PubMed, 2022). However, targeting the CNS is uniquely challenging due to the blood-brain barrier, which restricts the entry of many potential drugs (Frontiers in Pharmacology, 2020). Furthermore, the high risk of off-target effects within complex neural networks necessitates extreme precision in drug design (Nature Reviews Drug Discovery, 2021). Modern drug discovery efforts often focus on allosteric modulators to achieve higher specificity and fewer side effects compared to traditional orthosteric ligands (PubMed, 2022). Overall, CNS protein targets remain a critical but difficult frontier in medicine, requiring innovative delivery systems and deep biological insights.

Other names

NeurotargetsBrain protein targetsCNS receptorsCNS enzymesCentral nervous system targets

Pharmacological modulation including agonism, antagonism, allosteric modulation, and enzymatic inhibition across various protein classes (StatPearls, 2023; Nature Reviews Drug Discovery, 2021).